Hulio Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Hulio General Information

Description

Global Rights of global rights for Hulio (biosimilar Adalimumab).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Japan
Primary Industry
Buildings and Property
Acquirer
Corporate Office
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hulio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hulio‘s full profile, request access.

Request a free trial

Hulio Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hulio‘s full profile, request access.

Request a free trial

Hulio FAQs

  • Where is Hulio headquartered?

    Hulio is headquartered in Japan.

  • What industry is Hulio in?

    Hulio’s primary industry is Buildings and Property.

  • Is Hulio a private or public company?

    Hulio is a Private company.

  • What is Hulio’s current revenue?

    The current revenue for Hulio is .

  • Who are Hulio’s investors?

    Fujifilm Kyowa Kirin Biologics Company has invested in Hulio.

  • When was Hulio acquired?

    Hulio was acquired on 23-Dec-2025.

  • Who acquired Hulio?

    Hulio was acquired by Biocon Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process